Founder Margo Marrone Reacquires The Organic Pharmacy After Decade Under Ganassini

Margo Marrone has reacquired The Organic Pharmacy, the organic and natural beauty brand she founded, ending roughly a decade of ownership by Italian pharmaceutical group Istituto Ganassini.

The buyback closes the loop on a 2018 deal, when Marrone sold the business to the Milan-based group to secure its future growth. Terms of the reacquisition weren't disclosed. The Ganassini family will stay on as a partner, handling distribution of The Organic Pharmacy in Italy, while it refocuses its wider portfolio on other brands in the pharmaceutical industry.

Why did Marrone buy the brand back?

The company framed the return as a reset to the brand's founding philosophy of health, detoxification and lifestyle — a positioning that links skin health, internal wellbeing and healthy ageing. In a statement, the company noted Marrone's return comes as "holistic health, preventative wellness and longevity are increasingly central to the global wellness conversation."

"It was incredibly emotional to return to The Organic Pharmacy, and I feel so grateful to be back," Marrone said. "I am really looking forward to getting creative again and exploring what comes next for the brand."

She also restated the original vision that drove the brand at launch. "The Organic Pharmacy was the realisation of my dream: to bring under one roof professional client advice, an exceptional, personal service that enables me to form a bond with my clients, and the best products in the world that are free from toxins," Marrone said.

What happens to the Italian distribution arm?

The Ganassini family's continued role is distribution-only. Istituto Ganassini, a pharmaceutical group, will concentrate on other pharma brands in its portfolio going forward. That leaves Marrone with full strategic control of product development, retail and international expansion, while keeping an established route to market in Italy — historically a key European channel for the brand.

The structure suggests a clean handover rather than a joint operating model: Marrone owns and directs, Ganassini moves product in one national market.

Where does the product pipeline stand?

The brand arrives back in its founder's hands with recent momentum in actives. The Organic Pharmacy recently broke into the retinal category with the launch of Retinal Renewal Night Serum.

The brand claims the serum helps diminish pigmentation and reinforce the skin barrier during overnight use. Those are manufacturer claims; the company hasn't published trial data, PASI- or EASI-style endpoints or independent clinical evidence alongside the launch. Retinal — retinaldehyde, a retinoid one conversion step from retinoic acid — puts the brand in direct competition with dermatology-adjacent skincare lines that increasingly lead with the ingredient.

What does this mean for the natural-beauty sector?

Founder buybacks remain rare in a category dominated by consolidated group ownership. Marrone's exit in 2018 followed a familiar pattern: independent natural and organic brands selling to pharmaceutical or beauty conglomerates for scale and distribution. Her return inverts it, and she's betting the market has moved toward the brand's original thesis.

The timing argument is straightforward. Consumer and clinical conversations around longevity, preventative wellness and the gut–skin axis have moved closer to the holistic framing The Organic Pharmacy built its identity on two decades ago. A founder-led brand can iterate on that positioning faster than a committee inside a pharma group.

The open questions are execution ones. Marrone hasn't detailed specific growth targets, new retail plans or pipeline beyond the retinal launch. Whether the brand can convert wellness-conversation tailwinds into share against clinically positioned competitors — and whether Ganassini's Italian channel holds — will define the first chapter of her second tenure.